Dolgin, Elie. "Vaccine Protects Against HIV virus: A two-shot combo reduces the risk of HIV infection."Nature (2009). Nature. 24 Sept. 2009. 26 Sept. 2009, doi:10.1038/news.2009.947
This article was about latest development in the search for a HIV-1 Vaccine. For years we have have been trying to find a suitable vaccine for this pandemic. The search has seen many successes, but it seems to have had much more failures. This test was originally started in Thailand in 2003, and has just concluded. This trail tested the idea of administering a two-shot combination vaccine, and many were very skeptical. They were much more skeptical because of the fact that the two vaccines in question were vaccines that had previously failed to succeed in their individual trial tests. To everyone in the scientific world's surprise, this two-shot combination vaccine reduced the risk of contracting HIV by nearly 33%. This is the most success that any vaccine has ever had!
This two-shot combination vaccine is comprised of drugs made by Sanofi-Pasteur of Lyon, France, and VaxGen of Brisbane, Australia, both of which have failed individual trial testings. In general vaccines are supposed to have a 70-80% success rate in order to be considered for commercial use, but in the case of HIV they have lowered the success rate to 30%. This is because allowing a vaccine to be used even though it has 30% success rate can drastically decrease the now 2.5 million people per year infection rate. Lets hope that this break through is the one we have been looking for!
